Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers

Biopharmaceutics and Drug Disposition

Volumn 18, Issue 9, 1997, Pages 769-777

  Zhao, Jamie J ^a   Douglas Rogers, J ^a   Holland, Sherry D ^a   Larson, Patrick ^a   Amin, Raju D ^a   Haesen, Rita ^a   Freeman, Amanda ^a   Seiberling, M ^b   Merz, M ^b   Cheng, Haiyung ^a,c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b INNOVEX Biodesign GmbH   (Germany)

^c Watson Pharmaceuticals Inc   (United States)

Author keywords

Bioavailability; MK 0476; Montelukast sodium; Pharmacokinetics

Indexed keywords

MONTELUKAST;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

ACETATES; ADMINISTRATION, ORAL; ADULT; AGE FACTORS; AGED; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HALF-LIFE; HUMANS; MALE; MIDDLE AGED; QUINOLINES;

EID: 0030707608     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199712)18:9<769::AID-BDD60>3.0.CO;2-K     Document Type: Article

References (8)

1. 4 receptor antagonist devoid of peroxisomal enzyme induction. Bioorg. Med. Chem. Lett., 5, 283-288 (1995).
2. 4 receptor antagonist. Can. J. Physiol. Pharmacol., 73, 191-201 (1995).
3. 4-receptor antagonist, in healthy volunteers. Br. J. Clin. Pharmacol., in press.
4. H. Cheng, J. A. Leff, R. Amin, B. J. Gertz, M. De Smet, N. Noonan, J. D. Rogers, W. Malbercq, D. Meisner and G. Somers, Pharmacokinetics, bioavailability and safety of montelukast sodium (MK-0476) in healthy males and females. Pharm. Res., 13, 445-448 (1996).
5. R. D. Amin, H. Cheng and J. D. Rogers, Determination of MK-0476 in human plasma by liquid chromatography. J. Pharm. Biomed. Anal., 13, 155-158 (1995).
6. M. L. Rocci and W. J. Jusko, LAGRAN program for area and moments in pharmacokinetic analysis. Comput. Programs Biomed., 16, 203-216 (1983).
7. Data on file, Merck Research Laboratories.
8. D. J. Greenblatt, E. M. Sellers and R. I. Shader, Drug disposition in old age, New Engl. J. Med., 306, 1081-1088 (1982).